Still in the experimentalphase, researchers hope one day to produce personalized body parts on demand, despite many hurdles including ethical questions.
In addition, the experimental insomnia drug Suvorexant exhibited strong efficacy in phase III clinical trials as the drug helped insomnia patients fall asleep faster and stay asleep longer versus a placebo.